LortonA. Moving house? Call the professionals. Plus, 2021; 50:16(3):30–31.
2.
OstermannT. Information technology and integrative medicine: Intimate enemies or in-team mates?. J Altern Complement Med, 2021; 27(11):897–898.
3.
KimTH, KangJW, JeonSR, et al.Use of traditional, complementary and integrative medicine during the COVID-19 pandemic: A systematic review and meta-analysis. Front Med, 2022; 9:884573.
4.
RenM, LiuY, NiX, et al.The role of acupuncture and moxibustion in the treatment, prevention, and rehabilitation of patients with COVID-19: A scoping review. Integr Med Res, 2022; 11:100886.
5.
AngL, SongE, ZhangJ, et al.Herbal medicine for COVID-19: An overview of systematic reviews and meta-analysis. Phytomedicine, 2022; 102:154136.
6.
WuY, LoaizaJ, BanerjiR, et al.Structure-function relationships of the human vertebral endplate. JOR Spine, 2021; 4(3):e1170.
7.
NguyenHT, KoshelevaO, KreinovichV. So how to make group decisions? Arrow's impossibility theorem 70 years after. Asian J Econ Banking, 2021; 3:226–233.
8.
HongohV, MayburyD, LevesqueJ, et al.Multisystem Inflammatory Syndrome in Children: Decision analysis support for evaluating transmission risk of COVID-19 in places where people gather. Can Commun Dis Rep, 2021; 47(11):446.
9.
RossD. Social risk preference and pandemic management. Philosophers' Mag, 2020;(90):87–94.
10.
Cano-OrónL, Lopera-ParejaEH. Media and science policy: Who influences whom regarding complementary and alternative medicines regulation. Int J Press/Polit, 2021; 19401612211047587.
11.
WaynePM, BuringJE, EisenbergDM, et al.Cost-effectiveness of a team-based integrative medicine approach to the treatment of back pain. J Altern Complement Med, 2019; 25(S1):S138–S146.
12.
OstermannT, LaucheR, CramerH, et al.Comparative cost analysis of inpatient integrative medicine—Results of a pilot study. Complement Ther Med, 2017; 32:129–133.
13.
OstermannT, ParkAL, De JaegereS, et al.Cost-effectiveness analysis for SilAtro-5-90 adjuvant treatment in the management of recurrent tonsillitis, compared with usual care only. Cost Eff Resour Alloc, 2021; 19(1):1–15.
14.
HeYT, HuangXH, FangYY, et al.Cost-effectiveness evaluation of different control strategies for Clonorchis sinensis infection in a high endemic area of China: A modelling study. PLoS Negl Trop Dis, 2022; 16(5):e0010429.
15.
WittCM. Health economic studies on complementary and integrative medicine. Complement Med Res, 2011; 18(1):6–9.
